What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis, RCT).

Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Tenecteplase 0.25 mg/kg shows superior functional outcomes compared to alteplase in acute ischemic stroke patients.
Among 13 RCTs involving 9053 patients, tenecteplase outperformed alteplase in achieving excellent functional outcomes (p=0.008).
Following PRISMA 2020 guidelines, this systematic review used random effects models to analyze treatment efficacy.
The findings call for further exploration of tenecteplase as a viable alternative to alteplase in acute ischemic stroke treatment.

No takes yet. Share an insight, caveat, or question.

This systematic review compares tenecteplase and alteplase for acute ischemic stroke outcomes, showing tenecteplase may offer advantages.

Hagag et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark